Health and Wellness : Prostate cancer surveillance criteria may not be accurate for African American men

Discussion in 'Black Health and Wellness' started by Liberty, Jan 6, 2016.

  1. Liberty

    Liberty going above and beyond PREMIUM MEMBER

    Country:
    United States
    Joined:
    Aug 28, 2015
    Messages:
    5,874
    Likes Received:
    1,127
    Gender:
    Female
    Ratings:
    +3,242
    When to stop watchful waiting and begin definitive treatment of African American patients explored in The Journal of Urology

    New York, NY, January 4, 2016 - A new study published in The Journal of Urology® revealed that African American men with Gleason score 3+3=6 prostate cancer (PCa) produce less prostate specific antigen (PSA) and have significantly lower PSA density (PSAD) than Caucasian men. These findings could have important implications when selecting patients for inclusion in active PCa surveillance programs.

    Prostate cancer remains the second leading cause of cancer death among men in the U.S., with nearly 30,000 deaths annually. According to the latest recommendations by the American Urological Association, PSA remains the only screening test to select men with unremarkable digital rectal examination in whom prostate biopsy should be considered. Deaths from prostate cancer have declined by about 40% since the advent of PSA screening in the late 1980s, and 40-70% of that decline may be attributable to screening. For early stage low grade disease, active surveillance, commonly called watchful waiting, is considered appropriate.

    Read more

    http://www.eurekalert.org/pub_releases/2016-01/ehs-pcs010416.php
     
Loading...